COS通过调节自噬改善动脉粥样硬化进展

    COS improves atherosclerosis progression by modulating autophagy

    • 摘要: 动脉粥样硬化(atherosclerosis, AS)是导致我国居民死亡的主要原因之一。研究表明,AS斑块的形成是其病理基础,而自噬作为影响AS的关键因素之一,在AS斑块的形成中起着重要作用。壳寡糖(chitosan oligosaccharides, COS)是壳聚糖的水解产物,具有多种生物活性。研究表明,COS具有显著的生物学性质如抗菌、抗炎、抗氧化、抗肿瘤和免疫调节能力。然而,其对AS的影响机制仍需进一步探索。近年来,COS调节自噬在糖尿病心肌病、AS、冠心病、心肌肥厚和心力衰竭等心血管疾病中的作用得到初步验证。本文综述了此方面的研究进展,重点介绍COS对AS的影响机制及相关的自噬作用。

       

      Abstract: Atherosclerosis (AS) is one of the leading causes of death in China. Studies have shown that the formation of AS plaque is its pathological basis and autophagy, as one of the key factors affecting atherosclerosis, plays an important role in the formation of AS plaque. Shell is chitosan oligosaccharides (COS) hydrolysis product, with a variety of biological activity, research has shown that shell COS has significant biological properties such as antibacterial, anti-inflammatory, anti-oxidation, anti-tumor, as well as immune adjustment ability. However, the mechanism of the effect on AS still needs to be further explored and in recent years, the role of COS in regulating autophagy in cardiovascular diseases such as diabetic cardiomyopathy, atherosclerosis, coronary heart disease, myocardial hypertrophy and heart failure has been initially verified. This article reviews the research progress in this area, focusing on the mechanism of COS on AS and related autophagy.

       

    /

    返回文章
    返回